معرفی
David Phillips is a Research Associate and Research Visitor in the Department of Chemical Engineering at the University of Bath, affiliated with the Centre for Bioengineering & Biomedical Technologies (CBio). His work focuses on biomedical engineering, cell biology, and biomanufacturing, particularly in erythroid cell line development for red blood cell production. Phillips leads the EPSRC-funded project 'Fluidised bed bioreactors for large-scale manufacture of mammalian single cell suspension-derived therapeutics' as Principal Investigator (PI).
His research interests include regenerative medicine, bioreactor engineering, and therapeutic manufacturing, with a recent publication detailing novel erythroid cell line characterization. Phillips collaborates extensively in areas such as hematopoietic cell engineering and bioprocess optimization. The associated dataset for his 2025 paper is publicly available via the University of Bath repository (DOI: 10.15125/BATH-01456).
Grant activities include EPSRC funding (2024–2025) totaling £[redacted]. His work bridges chemical engineering and biomedical applications, advancing scalable cell-based therapeutics.
